The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call
The Oncology Institute (TOI), a leading value-based oncology group in the United States, has announced its second quarter 2024 earnings release date and conference call details. The company will release its financial results on Tuesday, August 13, 2024, after the market close. This will be followed by a conference call at 5:00 p.m. Eastern Time on the same day.
Investors can access the call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (international). A replay will be available until August 20, 2024, accessible via 1-844-512-2921 (US) or 1-412-317-6671 (international) with passcode 13747491. Additionally, a simultaneous webcast will be available on the company's Investor Relations website.
L'Istituto di Oncologia (TOI), un importante gruppo oncologico negli Stati Uniti basato sul valore, ha annunciato la data di rilascio dei risultati finanziari del secondo trimestre 2024 e i dettagli della conference call. L'azienda pubblicherà i suoi risultati finanziari il martedì 13 agosto 2024, dopo la chiusura del mercato. Questo sarà seguito da una conference call alle 17:00 ora orientale dello stesso giorno.
Gli investitori possono partecipare alla chiamata componendo il numero 1-877-407-0789 (USA) o 1-201-689-8562 (internazionale). Una registrazione sarà disponibile fino al 20 agosto 2024, accessibile tramite 1-844-512-2921 (USA) o 1-412-317-6671 (internazionale) con il codice di accesso 13747491. Inoltre, sarà disponibile una trasmissione web simultanea sul sito web delle Relazioni con gli Investitori dell'azienda.
El Instituto de Oncología (TOI), un grupo oncológico líder basado en el valor en los Estados Unidos, ha anunciado la fecha de liberación de sus ganancias del segundo trimestre de 2024 y los detalles de la conferencia telefónica. La compañía publicará sus resultados financieros el martes 13 de agosto de 2024, después del cierre del mercado. Esto será seguido por una conferencia telefónica a las 5:00 p.m. hora del Este el mismo día.
Los inversores pueden acceder a la llamada marcando 1-877-407-0789 (EE.UU.) o 1-201-689-8562 (internacional). Una repetición estará disponible hasta el 20 de agosto de 2024, accesible a través de 1-844-512-2921 (EE.UU.) o 1-412-317-6671 (internacional) con el código de acceso 13747491. Además, habrá una transmisión simultánea por web disponible en el sitio web de Relaciones con Inversores de la compañía.
종양학 연구소(TOI)는 미국에서 가치 기반의 종양학 그룹으로, 2024년 2분기 실적 발표 날짜와 컨퍼런스 콜 세부사항을 발표했습니다. 회사는 2024년 8월 13일 화요일 시장 마감 후 재무 결과를 발표할 예정입니다. 같은 날 동부 표준시 오후 5:00에 컨퍼런스 콜이 진행됩니다.
투자자들은 1-877-407-0789 (미국) 또는 1-201-689-8562 (국제)로 전화를 걸어 콜에 참여할 수 있습니다. 2024년 8월 20일까지 재생이 가능하며, 1-844-512-2921 (미국) 또는 1-412-317-6671 (국제)로 접속할 수 있으며, 패스코드 13747491가 필요합니다. 또한, 회사의 투자자 관계 웹사이트에서 동시 웨비나도 제공됩니다.
L'Institut d'Oncologie (TOI), un groupe d'oncologie basé sur la valeur leader aux États-Unis, a annoncé la date de publication de ses résultats du deuxième trimestre 2024 et les détails de la conférence téléphonique. L'entreprise publiera ses résultats financiers le mardi 13 août 2024, après la fermeture du marché. Cela sera suivi d'une conférence téléphonique à 17h00 heure de l'Est le même jour.
Les investisseurs peuvent accéder à l'appel en composant le 1-877-407-0789 (États-Unis) ou le 1-201-689-8562 (international). Une rediffusion sera disponible jusqu'au 20 août 2024, accessible via le 1-844-512-2921 (États-Unis) ou le 1-412-317-6671 (international) avec le code d'accès 13747491. De plus, une diffusion simultanée sur le web sera disponible sur le site Internet des relations avec les investisseurs de l'entreprise.
Das Onkologie-Institut (TOI), eine führende wertbasierte Onkologie-Gruppe in den Vereinigten Staaten, hat das Datum der Veröffentlichung der Ergebnisse für das zweite Quartal 2024 sowie die Einzelheiten zur Telefonkonferenz bekannt gegeben. Das Unternehmen wird seine finanziellen Ergebnisse am Dienstag, den 13. August 2024, nach Börsenschluss veröffentlichen. Dies wird von einer Telefonkonferenz am 17:00 Uhr Eastern Time am selben Tag gefolgt.
Investoren können an dem Anruf teilnehmen, indem sie 1-877-407-0789 (USA) oder 1-201-689-8562 (international) wählen. Eine Aufnahme wird bis zum 20. August 2024 verfügbar sein, erreichbar über 1-844-512-2921 (USA) oder 1-412-317-6671 (international) mit dem Zugangs-Code 13747491. Darüber hinaus wird eine gleichzeitige Webübertragung auf der Investor Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
CERRITOS, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its second quarter 2024 financial results after the market close on Tuesday, August 13, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13747491. The replay will be available until Tuesday, August 20, 2024.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
FAQ
When will The Oncology Institute (TOI) release its Q2 2024 earnings?
What time is TOI's Q2 2024 earnings conference call scheduled for?
How can investors access TOI's Q2 2024 earnings conference call?
Until what date will the replay of TOI's Q2 2024 earnings call be available?
